Moderator: Susan K. Boolbol, MD, FACS, New York, NY
Co-Moderator: Lee G. Wilke, MD, FACS, Madison, WI 

There is a wide array of treatment options for breast cancer but not all women benefit from each one. Genomic testing of specific tumor types has become of great interest in the evaluation of breast cancer. Assessment of the particular genetic alterations present in an individual’s tumor may provide information in regards to diagnosis, prognosis, and targeted treatment beyond the standard clinicopathological factors. Many gene-based assays are available, and they differ in regards to the intended patient populations, sample requirements, genes evaluated, results, and validation. This panel will discuss the different types of multi-gene signature tests that are available, clinical utility, and appropriate patient selection.
Course Outline  

Presentation and Speakers

Personalized Breast Cancer Treatment and Tumor Genomics
Susan K. Boolbol, MD, FACS, New York, NY
Lee G. Wilke, MD, FACS, Madison, WI